Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure / 南方医科大学学报
Journal of Southern Medical University
; (12): 1215-1216, 2014.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-312602
Responsible library:
WPRO
ABSTRACT
Recombinant activated factor VII (rFVIIa) is a novel therapeutic agent for life-threatening massive gastrointestinal bleeding. We report a case of massive gastrointestinal bleeding in a 78-year-old female patient with respiratory and renal failure. After failure of management of the bleeding with routine pharmacotherapy, we gave the patient rFVIIa injection at the dose of 20 µg/kg and the bleeding was rapidly controlled. Adverse side effects of the drug were not observed in this patient.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Respiratory Insufficiency
/
Recombinant Proteins
/
Factor VIIa
/
Therapeutic Uses
/
Drug Therapy
/
Renal Insufficiency
/
Gastrointestinal Hemorrhage
Limits:
Aged
/
Female
/
Humans
Language:
Chinese
Journal:
Journal of Southern Medical University
Year:
2014
Document type:
Article